Company / SG&A Expense
BICYCLE THERAPEUTICS PLC SG&A Expense History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$79.4M
FY2025
5-year range
$32.4M / $79.4M
FY2021-FY2025
Trend
+10.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
SG&A Expense has increased for 6 consecutive years, from $15M in FY2019 to $79M in FY2025.
Based on SEC 10-K filings.
$79M in FY2025 with a 5-year CAGR of +22.1%.
Increased from $60M to $79M over the past 2 years.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +17.0%
- 5-Year CAGR
- +22.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- BICYCLE THERAPEUTICS PLC's sg&a expense has grown for 6 consecutive years.
- 5-year CAGR of +22.1%, indicating consistent growth.
- In FY2025, sg&a expense increased 10.0% year-over-year.
- Lowest sg&a expense in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.98 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $79.4M | +10.0% |
| FY2024 | $72.2M | +19.5% |
| FY2023 | $60.4M | +22.1% |
| FY2022 | $49.5M | +52.6% |
| FY2021 | $32.4M | +11.1% |
| FY2020 | $29.2M | +100.6% |
| FY2019 | $14.6M | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 21, 2026